Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine for chronic myelomonocytic leukemia
2009-014561-77Phase 2Active
- Sponsor
- AISSM
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of decitabine in chronic myelomonocytic leukemia (CMML), sponsored by AISSM. Primary endpoint: Response rate (CR + PR). Started Nov 2009; status: active.
02
Drugs
decitabine
03
Conditions
chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on 2009-014561-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014561-77.